| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Braskem (NYSE:BAK) reported $3.618 billion in sales this quarter. This is a 3.34 percent decrease over sales of $3.743 billion the same period last year.
Posted In: BAK